Add-on dupilumab (Dupixent) significantly reduced itching and urticaria in patients with chronic spontaneous urticaria (CSU) ...

.r29-article .byline a, .r29-article .footer .byline.featured-contributors .featured-name { pointer-events: none !important; ...

In adults, CSU and CIndU affect twice as ... data from the ongoing ASSURE-CRU study showed some improvement in the treatment of chronic urticaria. Nevertheless, the rates of under-treatment ...

Background: Chronic idiopathic urticaria is a distressing condition ... the health economic impact of daily levocetirizine treatment in adults with CIU. This is the first paper to address this ...

Dupixent significantly reduced itch and hive activity from baseline; 41% of patients achieved well-controlled disease statusConfirmatory data to ...

And beyond the physical symptoms, plaque psoriasis also frequently has negative effects on mental health and alters the ...

“Patients with uncontrolled chronic spontaneous urticaria experience ... for the maintenance treatment of chronic rhinosinusitis with nasal polyposis (CRSwNP) in adults whose disease is not ...

On Monday, Jasper Therapeutics Inc (NASDAQ:JSPR) stock is trading higher after the company reported preliminary data from its ...

Study C enrolled 151 children and adults who were randomized to receive Dupixent ... such as Dupixent for the treatment of chronic spontaneous urticaria (“CSU”) as discussed in this press release as ...

Sanofi to present dupixent late-breaking positive phase 3 data in chronic spontaneous urticaria at ACAAI: Paris Saturday, October 26, 2024, 12:00 Hrs [IST] Positive data from the ...

Dupixent late-breaking positive phase 3 data in chronic spontaneous urticaria to be presented at ACAAI Dupixent significantly reduced itch and hive activity from baseline; 41% of patients achieved ...

Study C enrolled 151 children and adults who were randomized to receive Dupixent ... such as Dupixent for the treatment of chronic spontaneous urticaria ("CSU") as discussed in this press release as ...